Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maimoena S. S. Guman"'
Autor:
Sylke Haal, Maimoena S. S. Guman, L. Maurits de Brauw, Ruben N. van Veen, Ruben Schouten, Paul Fockens, Victor E. A. Gerdes, Marcel G. W. Dijkgraaf, Rogier P. Voermans
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Approximately 8–15% of patients undergoing bariatric surgery develop symptomatic gallstone disease within 24 months after surgery. Ursodeoxycholic acid (UDCA) seems to effectively prevent the formation of gallstones detectable b
Externí odkaz:
https://doaj.org/article/d81e256b83b44cf4b339b7b06e50477d
Autor:
Sylke Haal, Maimoena S. S. Guman, Yair I. Z. Acherman, Johannes P. G. Jansen, Michel van Weeghel, Henk van Lenthe, Eric J. M. Wever, Victor E. A. Gerdes, Rogier P. Voermans, Albert K. Groen
Publikováno v:
Metabolites, Vol 11, Iss 10, p 682 (2021)
Since obese patients form cholesterol gallstones very rapidly after bariatric surgery, in patients who did not form gallstones during preceding years, we hypothesized that gallstone formation follows a different trajectory in bariatric patients compa
Externí odkaz:
https://doaj.org/article/6fc8145cc0884ba1971d1cde76cfd3e1
Autor:
Maimoena S. S. Guman, Sylke Haal, Yair I. Z. Acherman, Arnold W. L. van de Laar, Max Nieuwdorp, Rogier P. Voermans, Victor E. A. Gerdes
Publikováno v:
Guman, M S S, Haal, S, Acherman, Y I Z, van de Laar, A W L, Nieuwdorp, M, Voermans, R P & Gerdes, V E A 2023, ' Ursodeoxycholic Acid Use After Bariatric Surgery : Effects on Metabolic and Inflammatory Blood Markers ', Obesity Surgery, vol. 33, no. 6, pp. 1773-1781 . https://doi.org/10.1007/s11695-023-06581-8
Obesity surgery, 33(6), 1773-1781. Springer New York
Obesity Surgery, 33(6), 1773-1781. Springer New York
Obesity surgery, 33(6), 1773-1781. Springer New York
Obesity Surgery, 33(6), 1773-1781. Springer New York
Background In addition to the reduction of symptomatic gallstone disease, ursodeoxycholic acid (UDCA) might also have beneficial metabolic effects after bariatric surgery. We examined the impact of UDCA on liver enzymes, hemoglobin A1c (HbA1c), lipid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa466351df2e27ad585cb530c81af71
http://www.scopus.com/inward/record.url?scp=85153342206&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85153342206&partnerID=8YFLogxK
Autor:
Ruben N. van Veen, L. Maurits de Brauw, Thomas C. C. Boerlage, Steve M. M. de Castro, Rogier P. Voermans, Manon Schouten, Ruben Schouten, Yair I. Z. Acherman, Arnold W. J. M. van de Laar, Claire E E de Vries, Jeanin E. van Hooft, Ellert J. van Soest, Daan E. Moes, Marcel G. W. Dijkgraaf, Sjoerd Bruin, Paul Fockens, Victor E. A. Gerdes, Maimoena S. S. Guman, Sylke Haal
Publikováno v:
The Lancet Gastroenterology & Hepatology, 6(12), 993-1001. ELSEVIER INC
lancet. Gastroenterology & hepatology, 6(12), 993-1001. Elsevier Limited
lancet. Gastroenterology & hepatology, 6(12), 993-1001. Elsevier Limited
Background Rapid weight loss is a major risk factor for the formation of cholesterol gallstones. Consequently, patients with morbid obesity undergoing bariatric surgery frequently develop symptomatic gallstone disease. This trial assessed the efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8ecc5403f3722d69a3e3f33c0b376b3
https://hdl.handle.net/1887/3276811
https://hdl.handle.net/1887/3276811
